基本信息
views: 131
Career Trajectory
Bio
Giovanna Roncador obtained a Bachelor’s Degree in Biology from Bologna University in 1994, and a PhD degree in Biology from the Universidad Autónoma de Madrid in 2012. From 1994 to 1996 she worked as the person in charge of the routine diagnostic immunohistochemistry procedures in the diagnostic laboratory, as well as the immunophenotypic characterisation of lymphomas for research projects, at the Department of Haemolymphopathology of Bologna University. In 1997 she moved to the Nuffield Department of Clinical Laboratory Sciences at Oxford University, where she specialised in monoclonal antibodies technology, focusing in the production and characterization of monoclonal antibodies for the diagnosis of lymphomas.
In October 2000 she joined the CNIO as Head of the Monoclonal Antibodies Unit, to set up the monoclonal antibodies technology at this institution, supervising a team of 3-4 technicians. The technical and scientific excellence of the Unit is evidenced by its trajectory of more than 23 years resulting in the production of around 200 mAbs, mostly directed against markers used for research and diagnosis of cancer. This work has resulted in the publication of a total of 88 research articles in peer-reviewed journals of international relevance, where she is co-author or corresponding author. She has supervised one doctoral thesis and is involved in different activities related to training and education of young researchers and technicians. Since 2009 she is the founder and chair of EuroMabNet (www.euromabnet.con), the first European non-profit organization of multidisciplinary academic laboratories with internationally recognised reputations in generating and using validated monoclonal antibodies.
Also, she is deeply involved in activities of transference of technology: 68 of the high quality antibodies produced by the Unit since 2005 have been licensed to the most prestigious international companies operating in this field (BD, Bioscience, eBioscience, Biolegend, Sigma, Abcam, Millipore, etc.) generating an important economic return for the CNIO in royalties. Each year the Unit releases a catalogue antibodies available for licensing (more than 100), containing their validation data (accessible at http://www.cnio.es/ing/servicios/anticuerpos/default.Aspx and https://www.cnio.es/es/servicios/anticuerpos/datasheet.aspx). The antibodies produced by the Unit have been applied as valuable tools for cancer research and diagnosis, both in hospitals of the National Health System and in national and international research institutions. In addition, she has established collaborations with pharmaceutical and biotech companies (Merck, Lilly, R-Biopharm) for the production of antibodies against molecules involved in cancer development.
Research Interests
Papers共 163 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Joaquim Carreras,Haruka Ikoma,Yara Yukie Kikuti,Masashi Miyaoka,Shinichiro Hiraiwa,Sakura Tomita,Yusuke Kondo,Atsushi Ito, Shunsuke Nagase, Hisanobu Miura,Hiroshi Kawada,Giovanna Roncador,
Joaquim Carreras, Yara Yukie Kikuti,Masashi Miyaoka, Saya Miyahara,Giovanna Roncador, Rifat Hamoudi,Naoya Nakamura
BioMedInformaticsno. 1 (2024): 295-320
Modern Pathologyno. 9 (2024): 100551-100551
International journal of cancerno. 6 (2023): 1300-1312
Maria-Luisa Del Rio, Carla Yago-Diez de Juan,Giovanna Roncador,Eduardo Caleiras,Ramón Álvarez-Esteban, José Antonio Pérez-Simón,Jose-Ignacio Rodriguez-Barbosa
Frontiers in immunology (2023): 1113858
HEMATOLOGY REPORTSno. 1 (2023): 188-200
JOURNAL OF PATHOLOGY (2023): S23-S24
Cited0Views0Bibtex
0
0
Nature medicineno. 3 (2023): 632-645
JOURNAL OF PATHOLOGY (2023): S23-S23
Cited0Views0Bibtex
0
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn